Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 5:29 PM
Ignite Modification Date:
2025-12-24 @ 5:29 PM
NCT ID:
NCT00849368
Brief Summary:
Main Study Objectives:
The study is conducted to
* evaluate the minimal allopurinol and azathioprine doses that, in combination, produce therapeutic 6-TGN levels
* evaluate the safety and tolerability of the different allopurinol/azathioprine dose levels
* assess if concomitant allopurinol affects TPMT activity
* assess the clinical efficacy of concomitant allopurinol-azathioprine therapy in the included patients
Study:
NCT00849368
Study Brief:
Protocol Section:
NCT00849368